HDMA announces 2014 DIANA Winners

ARLINGTON, Va. — HDMA on Tuesday honored pharmaceutical and consumer product manufacturers at its 2014 Business and Leadership Conference in Phoenix, through the presentation of the Association’s annual Distribution Industry Awards for Notable Achievements in Healthcare (the DIANA awards). 

The DIANA awards have recognized supply chain excellence and successful trading partner relationships since 1959. The awards honor pharmaceutical and consumer product manufacturers for developing innovative new product introductions and promotions for the healthcare distribution industry. Manufacturers also are recognized for advancing trade relations by fostering strong trading partner relationships with HDMA distributor members and creating exceptional business practices that benefit the entire healthcare supply chain.

In addition, presented for the second year, the DIANA Manufacturer Partner of the Year recognizes companies for their active participation in the Association. The winning companies have at least five consecutive years of membership, regularly participate in HDMA conferences, serve on Association committees, and show support through event attendance and sponsorships.

2014 DIANA Manufacturer Partner of the Year Winners:

• HDMA Manufacturer Member With Sales to Healthcare Distributors of More Than $50 Million: Mylan


• HDMA Manufacturer Member With Sales to Healthcare Distributors of Less Than $50 Million: Upsher-Smith Laboratories.

2014 DIANA Winners:

Best New Product Introduction or Promotion Awards:

• Branded Pharmaceutical Products: Eisai for Belviq;


• Generic Pharmaceutical Products: Citron Pharma for duloxetine DR capsules USP; and


• Over-the-Counter and Home Healthcare Products: Merck Consumer Care, for Oxytrol for Women.

 Best Overall Manufacturer Awards:

• Branded Pharmaceutical Product Manufacturer with Sales to Healthcare Distributors of Less Than $300 Million: Depomed;


• Branded Pharmaceutical Product Manufacturer with Sales to Healthcare Distributors of More Than $300 Million: Forest Pharmaceuticals;


• Generic Pharmaceutical Product Manufacturer with Sales to Healthcare Distributors of Less Than $100 Million: Alvogen;


• Generic Pharmaceutical Product Manufacturer with Sales to Healthcare Distributors of More Than $100 Million: Actavis; and


• Consumer Product Manufacturer: BD Medical – Diabetes Care.